Table of Content

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 GROWTH FORECAST 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE AUTOIMMUNE
DISEASE DIAGNOSIS MARKET 30
4.2 ASIA PACIFIC MARKET: BY DISEASE 31
4.3 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GEOGRAPHIC SNAPSHOT 32

5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 High incidence and prevalence of autoimmune diseases 34
5.2.1.2 Increasing awareness about autoimmune diseases 35
5.2.1.3 Growth in the number of research activities on autoimmune diseases 35
5.2.2 RESTRAINTS 36
5.2.2.1 High capital requirements 36
?
5.2.3 OPPORTUNITIES 36
5.2.3.1 Use of biosensors for autoimmune disease diagnosis 36
5.2.4 TRENDS 37
5.2.4.1 Growth in the number of reagent rental agreements 37

6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 38
6.1 INTRODUCTION 39
6.2 CONSUMABLES & ASSAY KITS 39
6.2.1 NEED FOR THE RAPID DETECTION OF AUTOIMMUNE DISEASES TO DRIVE
THE DEMAND FOR CONSUMABLES AND ASSAY KITS 39
6.3 INSTRUMENTS 40
6.3.1 INSTRUMENTS SEGMENT TO RECORD SIGNIFICANT GROWTH DURING THE FORECAST PERIOD 40

7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 42
7.1 INTRODUCTION 43
7.2 ROUTINE LABORATORY TESTS 43
7.2.1 RISING NUMBER OF ROUTINE HEALTH CHECK-UPS TO
SUPPORT MARKET GROWTH 43
7.3 INFLAMMATORY MARKERS 44
7.3.1 ABILITY OF INFLAMMATORY MARKERS TO DETECT ABNORMALITIES EFFICIENTLY TO DRIVE THEIR DEMAND 44
7.4 AUTOANTIBODIES AND IMMUNOLOGIC TESTS 45
7.4.1 ADOPTION OF NOVEL IMMUNOLOGY TESTS TO DRIVE MARKET GROWTH 45
7.5 OTHER TESTS 46

8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 47
8.1 INTRODUCTION 48
8.2 RHEUMATOID ARTHRITIS 48
8.2.1 INCREASING INCIDENCE OF RHEUMATOID ARTHRITIS TO
SUPPORT MARKET GROWTH 48
8.3 SYSTEMIC LUPUS ERYTHEMATOSUS 49
8.3.1 RISING PREVALENCE OF LUPUS TO SUPPORT MARKET GROWTH 49
8.4 SJ?GREN’S SYNDROME 50
8.4.1 RISING AWARENESS REGARDING SJ?GREN’S SYNDROME TO
SUPPORT MARKET GROWTH 50
8.5 THYROIDITIS 51
8.5.1 RISING PREVALENCE OF THYROID DISORDERS TO DRIVE MARKET GROWTH 51
8.6 SCLERODERMA 52
8.6.1 INCREASING INCIDENCE OF SKIN DISORDERS TO DRIVE MARKET GROWTH 52
8.7 OTHER DISEASES 53
?

9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 54
9.1 INTRODUCTION 55
9.2 CLINICAL LABORATORIES 55
9.2.1 INCREASING INCIDENCE OF AUTOIMMUNE DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES 55
9.3 HOSPITALS 56
9.3.1 INCREASING GOVERNMENT INITIATIVES TO PROVIDE QUALITY TREATMENT FOR AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH 56
9.4 OTHER END USERS 57

10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION 58
10.1 INTRODUCTION 59
10.2 NORTH AMERICA 59
10.2.1 US 62
10.2.1.1 Rising expenditure on autoimmune disease R&D to drive market growth in the US 62
10.2.2 CANADA 64
10.2.2.1 Rising prevalence of autoimmune diseases to support market growth 64
10.3 EUROPE 66
10.3.1 GERMANY 69
10.3.1.1 Rising healthcare expenditure to drive market growth in Germany 69
10.3.2 UK 71
10.3.2.1 Rising prevalence of autoimmune diseases to drive market growth in the UK 71
10.3.3 FRANCE 73
10.3.3.1 High prevalence of multiple sclerosis to drive market growth in France 73
10.3.4 ITALY 74
10.3.4.1 Increasing life science R&D expenditure to support market
growth in Italy 74
10.3.5 SPAIN 76
10.3.5.1 Research activities conducted in the country to drive market growth in Spain 76
10.3.6 REST OF EUROPE 77
10.4 ASIA PACIFIC 79
10.4.1 CHINA 82
10.4.1.1 Outbreak of COVID-19 to hamper market growth during the
forecast period 82
10.4.2 INDIA 84
10.4.2.1 Development of antibody tests to support market growth in India 84
10.4.3 JAPAN 85
10.4.3.1 Rising healthcare expenditure to support market growth in Japan 85
10.4.4 AUSTRALIA 87
10.4.4.1 Rising prevalence of autoimmune diseases to drive market growth
in Australia 87
10.4.5 REST OF ASIA PACIFIC 89
10.5 MIDDLE EAST & AFRICA 90
10.5.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST AND AFRICA 90
10.6 LATIN AMERICA 92
10.6.1 HIGH PREVALENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH IN LATIN AMERICA 92

11 COMPETITIVE LANDSCAPE 94
11.1 OVERVIEW 94
11.2 MARKET SHARE ANALYSIS, 2018 95
11.3 COMPETITIVE SCENARIO 96
11.3.1 PRODUCT LAUNCHES (2017-2020) 96
11.3.2 PRODUCT APPROVALS (2017-2020) 97
11.3.3 PARTNERSHIPS 97
11.3.4 ACQUISITIONS (2017-2020) 97
11.3.5 COLLABORATIONS (2017-2020) 98
11.4 COMPETITIVE LEADERSHIP MAPPING (2018) 98
11.4.1 VISIONARY LEADERS 99
11.4.2 INNOVATORS 99
11.4.3 DYNAMIC DIFFERENTIATORS 99
11.4.4 EMERGING COMPANIES 99

12 COMPANY PROFILES 101
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1 THERMO FISHER SCIENTIFIC 101
12.2 SIEMENS 104
12.3 ABBOTT 106
12.4 DANAHER 109
12.5 BIO-RAD LABORATORIES 111
12.6 GRIFOLS 114
12.7 TRINITY BIOTECH 116
12.8 WERFEN 118
12.9 HYCOR BIOMEDICAL 120
12.10 EUROIMMUN 122
12.11 ONCIMMUNE 127
12.12 HTG MOLECULAR DIAGNOSTICS, INC. 129
12.13 SERAMUN DIAGNOSTICA GMBH 131
12.14 EXAGEN INC. 132
12.15 CAMBRIDGE LIFE SCIENCES LIMITED 135
12.16 A. MENARINI DIAGNOSTICS S.R.L 137
12.17 ORGENTEC DIAGNOSTIKA 138
12.18 KRONUS 139
12.19 ERBA GROUP 140
12.20 AESKU.GROUP GMBH & CO. KG 142
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

13 APPENDIX 143
13.1 INSIGHTS FROM INDUSTRY EXPERTS 143
13.2 DISCUSSION GUIDE 144
13.3 KNOWLEDGE STORE 147
13.4 AVAILABLE CUSTOMIZATIONS 149
13.5 RELATED REPORTS 149
13.6 AUTHOR DETAILS 150



List of Figures



FIGURE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION 18
FIGURE 2 RESEARCH DESIGN 20
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE DESIGNATION, AND REGION 22
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 22
FIGURE 5 MARKET SIZE ESTIMATION FROM THE PARENT MARKET 23
FIGURE 6 DATA TRIANGULATION METHODOLOGY 24
FIGURE 7 ASSUMPTIONS FOR THE STUDY 25
FIGURE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2020 VS. 2025 (USD MILLION) 26
FIGURE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2020 VS. 2025 (USD MILLION) 27
FIGURE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2020 VS. 2025 (USD MILLION) 27
FIGURE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2020 VS. 2025 (USD MILLION) 28
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE
DIAGNOSIS MARKET 29
FIGURE 13 HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 30
FIGURE 14 RHEUMATOID ARTHRITIS SEGMENT DOMINATED THE APAC MARKET IN 2019 31
FIGURE 15 JAPAN TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 32
FIGURE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS 33
FIGURE 17 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 60
FIGURE 18 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 67
FIGURE 19 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 80
FIGURE 20 PRODUCT LAUNCHES–THE MOST ADOPTED GROWTH STRATEGY
FROM 2017 TO 2020 94
FIGURE 21 SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET (2018) 95
FIGURE 22 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2018 100
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 101
FIGURE 24 SIEMENS: COMPANY SNAPSHOT 104
FIGURE 25 ABBOTT: COMPANY SNAPSHOT 106
FIGURE 26 DANAHER: COMPANY SNAPSHOT 109
FIGURE 27 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 111
FIGURE 28 GRIFOLS: COMPANY SNAPSHOT 114
FIGURE 29 TRINITY BIOTECH: COMPANY SNAPSHOT 116
FIGURE 30 WERFEN: COMPANY SNAPSHOT 118
FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT 122
?
FIGURE 32 ONCIMMUNE: COMPANY SNAPSHOT 127
FIGURE 33 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY SNAPSHOT 129
FIGURE 34 EXAGEN INC.: COMPANY SNAPSHOT 132

 

List of Tables



TABLE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 39
TABLE 2 AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES & ASSAY KITS MARKET BY REGION, 2018–2025 (USD MILLION) 40
TABLE 3 AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION 2018–2025 (USD MILLION) 41
TABLE 4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 43
TABLE 5 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2018–2025 (USD MILLION) 44
TABLE 6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS BY REGION, 2018–2025 (USD MILLION) 45
TABLE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2018–2025 (USD MILLION) 46
TABLE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2018–2025 (USD MILLION) 46
TABLE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 48
TABLE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS BY REGION, 2018–2025 (USD MILLION) 49
TABLE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018–2025 (USD MILLION) 50
TABLE 12 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJ?GREN’S SYNDROME BY REGION, 2018–2025 (USD MILLION) 51
TABLE 13 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION 2018–2025 (USD MILLION) 52
TABLE 14 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2018–2025 (USD MILLION) 52
TABLE 15 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION) 53
TABLE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 55
TABLE 17 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES BY REGION, 2018–2025 (USD MILLION) 56
TABLE 18 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION 2018–2025 (USD MILLION) 57
TABLE 19 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION) 57
TABLE 20 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION 2018–2025 (USD MILLION) 59
TABLE 21 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 61
TABLE 23 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION) 61
TABLE 24 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION) 61
TABLE 25 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION) 62
TABLE 26 EXPENDITURE ON AUTOIMMUNE DISEASE R&D BY THE NATIONAL INSTITUTES OF HEALTH, 2016–2019 62
TABLE 27 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 63
TABLE 28 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 63
TABLE 29 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 63
TABLE 30 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 64
TABLE 31 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 64
TABLE 32 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 65
TABLE 33 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 65
TABLE 34 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 65
TABLE 35 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 68
TABLE 36 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 68
TABLE 37 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 68
TABLE 38 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 69
TABLE 39 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 69
TABLE 40 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 70
TABLE 41 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 70
TABLE 42 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 70
TABLE 43 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 71
TABLE 44 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 71
TABLE 45 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 72
TABLE 46 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 72
TABLE 47 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 72
TABLE 48 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 73
TABLE 49 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 73
TABLE 50 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 74
TABLE 51 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 74
TABLE 52 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 75
TABLE 53 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 75
TABLE 54 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 75
TABLE 55 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 76
TABLE 56 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 76
TABLE 57 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 76
TABLE 58 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 77
TABLE 59 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 77
TABLE 60 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 78
TABLE 61 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION) 78
TABLE 62 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION) 78
TABLE 63 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION) 79
TABLE 64 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 80
TABLE 65 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 81
TABLE 66 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 81
TABLE 67 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 81
TABLE 68 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 82
TABLE 69 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 82
TABLE 70 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 83
TABLE 71 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 83
TABLE 72 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 83
TABLE 73 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 84
TABLE 74 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 84
TABLE 75 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 85
TABLE 76 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 85
TABLE 77 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 86
TABLE 78 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 86
TABLE 79 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 86
TABLE 80 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 87
TABLE 81 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT 2018–2025 (USD MILLION) 87
TABLE 82 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 2018–2025 (USD MILLION) 88
TABLE 83 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 88
TABLE 84 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 2018–2025 (USD MILLION) 88
TABLE 85 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 89
TABLE 86 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION) 89
TABLE 87 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION) 90
TABLE 88 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION) 90
TABLE 89 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET BY PRODUCT, 2018–2025 (USD MILLION) 91
TABLE 90 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET BY TEST TYPE, 2018–2025 (USD MILLION) 91
TABLE 91 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION) 91
TABLE 92 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET BY END USER, 2018–2025 (USD MILLION) 92
TABLE 93 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 92
TABLE 94 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION) 93
TABLE 95 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 2018–2025 (USD MILLION) 93
TABLE 96 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION) 93